The Cost/Benefit Analysis Project
This project presents a cost/benefit analysis of the Carolina Abecedarian Project and the Carolina Approach to Responsive Education (Abecedarian/CARE). Abecedarian/CARE targeted a group of disadvantaged families with children born between 1972 and 1979 in Chapel Hill, North Carolina. The intervention was randomized, with the treatment group receiving center-based childcare from birth though age 5. Rich data on the individuals are collected through age 35.
We calculate the effect of Abecedarian/CARE on life-cycle outcomes including health, employment, education, and crime. These treatment effects account for the fact that about 75% of the control group attended alternative center-based childcare (see Figure 1).
In order to calculate the life-cycle benefit/cost ratio and internal rate of return of the program, we need to understand the impact of Abecedarian/CARE beyond age 35. To predict the later-life outcomes of the Abecedarian/CARE subjects, we use auxiliary datasets that contain longitudinal information on individuals beyond age 35. We project income, welfare participation, crime, and health. Table 1 lists the auxiliary datasets we use for these projections.
The main estimates for the net present value of the treatment effects on the different components are presented in Figure 3. These net present values give the benefit/cost ratios and internal rates of return in Table 2. The pooled estimate of 6.29 implies that Abecedarian/CARE is a cost-effective early childhood intervention.
The Center for the Economics of Human Development launched the Cost/Benefit Analysis of the Perry Preschool Program in 2018. Information on the project available here.
Publications
Quantifying the Life-cycle Benefits of an Influential Early Childhood Program
This paper estimates the large array of long-run benefits of an influential early childhood program targeted to disadvantaged children and their families Learn more.
Frequently Asked Questions
Figure 1: Control Substitution, Cumulative Enrollment
Figure 3: Net Present Value of Main Components of the Cost/Benefit Analysis Over the Life Cycle per Program Participant, Treatment vs. Next Best
Table 1: Auxiliary Data Sources for Interpolation and Extrapolation of Life-cycle Benefits and Costs
|
Subject’s Age |
|||||
16-20 |
21-30 |
31-34 |
35-50 |
51-67 |
68-Death |
|
Labor Income |
|
CNLSY |
NLSY79; PSID |
|
|
|
Welfare |
|
CNLSY |
NLSY79; PSID |
|
|
|
Health |
PSID; MEPS; MCBS; HRS |
|||||
Crime |
NCDPS; NJRP; NVS; UCRS |
|
|
Table 2: Cost/Benefit Analysis, Treatment vs. Next Best
|
Males |
Females |
Pooled |
Benefit/Cost Ratio |
10.19 |
2.61 |
7.33 |
(2.93) |
(0.73) |
(1.84) |
|
Internal Rate of Return |
14.7% |
10.1% |
13.7% |
(4.2%) |
(6.0%) |
(3.3%) |
Note: Standard errors are in parentheses. Bolded estimates indicate significance at the 10% level.
Project Team
Jorge Luís García
Clemson
Sylvi Kuperman
The University of Chicago